Angiomax vs. Heparin Booth Display Can’t Withstand Weight Of FDA Scrutiny
This article was originally published in The Pink Sheet Daily
Executive Summary
Although The Medicines Co. cited multiple studies to buttress superiority claims for its angina treatment Angiomax (bivalirudin), FDA found that none of these studies actually supported the idea that the drug is superior to heparin.